Presence of Antibodies against Genogroup VI Norovirus in Humans

Virology Journal (Impact Factor: 2.18). 06/2013; 10(1):176. DOI: 10.1186/1743-422X-10-176
Source: PubMed


Noroviruses are important enteric pathogens in humans and animals. Recently, we reported a novel canine norovirus (CaNoV) in dogs with diarrhea belonging to a new genogroup (GVI). No data are available on exposure of humans to this virus.

Sera from 373 small animal veterinarians and 120 age-matched population controls were tested for IgG antibodies to CaNoV by a recombinant virus like particle based enzyme-linked immunosorbent assay.

Antibodies to CaNoV were found in 22.3% of the veterinarians and 5.8% of the control group (p < 0.001). Mean corrected OD450 values for CaNoV antibodies were significantly higher in small animal veterinarians compared to the control group.

These findings suggest that CaNoV may infect humans and small animal veterinarians are at an increased risk for exposure to this virus. Additional studies are needed to assess if this virus is able to cause disease in humans.

Download full-text


Available from: Jan Vinjé,
  • Source
    • "For example, HuNVs can infect gnotobiotic piglets (Cheetham et al., 2006) and there is serological evidence of HuNV in pigs (Farkas et al., 2005). Whilst antibodies to GVI noroviruses have been identified in veterinarians, it has yet to be determined whether infection results in clinical disease (Mesquita et al., 2013). Additional studies are required to further elucidate the zoonotic potential of noroviruses and whether animals represent a reservoir from which new strains may emerge. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Noroviruses are small positive sense RNA viruses within the Caliciviridae family and are now widely accepted as a major cause of acute gastroenteritis in both developed and developing countries. Despite their impact, our understanding of the life cycle of noroviruses has lagged behind that of other RNA viruses due to the inability to culture human noroviruses. Our knowledge of norovirus biology has significantly improved over the past decade as a result of numerous technological advances. The use of a human norovirus replicon, improved biochemical and cell based assays, combined with the discovery of a murine norovirus capable of replication in cell culture, has greatly improved our understanding of the molecular mechanisms of norovirus genome translation and replication, as well as the interaction with host cell processes. In this review, the current state of knowledge of the intracellular life of noroviruses is discussed with particular emphasis on the mechanisms of viral gene expression and viral genome replication.
    Journal of General Virology 11/2013; 95(Pt_2). DOI:10.1099/vir.0.059634-0 · 3.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the prevalence of the recently described genogroup VI canine noroviruses (CNVs) in dogs in Europe, 510 serum samples from dogs in 14 European countries were tested for anti-IgG CNV antibodies.Seropositive dogs were found widespread throughout Europe. Dogs exclusively with antibodies against human noroviruses were also found.
    Clinical and vaccine Immunology: CVI 03/2014; 21(6). DOI:10.1128/CVI.00048-14 · 2.47 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sapovirus, a member of the Caliciviridae family, is an important cause of acute gastroenteritis in humans and pigs. Currently, the porcine sapovirus (PSaV) Cowden strain remains the only cultivable member of the Sapovirus genus. While some caliciviruses are known to utilize carbohydrate receptors for entry and infection, a functional receptor for sapovirus is unknown. To characterize the functional receptor of the Cowden strain of PSaV, we undertook a comprehensive series of protein-ligand biochemical assays in mock and PSaV-infected cell culture and/or piglet intestinal tissue sections. PSaV revealed neither hemagglutination activity with red blood cells from any species nor binding activity to synthetic histo-blood group antigens, indicating that PSaV does not use histo-blood group antigens as receptors. Attachment and infection of PSaV were markedly blocked by sialic acid and Vibrio cholerae neuraminidase (NA), suggesting a role for α2,3-linked, α2,6-linked or α2,8-linked sialic acid in virus attachment. However, viral attachment and infection were only partially inhibited by treatment of cells with sialidase S (SS) or Maackia amurensis lectin (MAL), both specific for α2,3-linked sialic acid, or Sambucus nigra lectin (SNL), specific for α2,6-linked sialic acid. These results indicated that PSaV recognizes both α2,3- and α2,6-linked sialic acids for viral attachment and infection. Treatment of cells with proteases or with benzyl 4-O-β-D-galactopyranosyl-β-D-glucopyranoside (benzylGalNAc), which inhibits O-linked glycosylation, also reduced virus binding and infection, whereas inhibition of glycolipd synthesis or N-linked glycosylation had no such effect on virus binding or infection. These data suggest PSaV binds to cellular receptors that consist of α2,3- and α2,6-linked sialic acids on glycoproteins attached via O-linked glycosylation.
    PLoS Pathogens 06/2014; 10(6):e1004172. DOI:10.1371/journal.ppat.1004172 · 7.56 Impact Factor
Show more